There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research ...
Researchers have developed a sustainable catalyst that increases its activity during use while converting carbon dioxide (CO2) into valuable products. This discovery offers a blueprint for designing ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
The stock's fall snapped a three-day winning streak.
Shares of Catalyst Pharmaceuticals Inc. CPRX rose 1.34% to $23.40 Wednesday, on what proved to be an all-around favorable ...
6d
Hosted on MSNBaird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform RecommendationFintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a Outperform recommendation. Analyst Price Forecast Suggests 47.68% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results